Filter
347
Filtered Results: 347
Text search:
anamnese
Featured
Recommendations
58
New Publications
80
Language
Document type
No document type
182
Guidelines
85
Manuals
23
Studies & Reports
20
Fact sheets
14
Resource Platforms
10
Brochures
4
Training Material
3
Infographics
3
Strategic & Response Plan
3
Countries / Regions
Germany
100
Indonesia
24
Brazil
17
Argentina
16
Colombia
15
Western and Central Europe
15
Paraguay
9
Bolivia
7
Ecuador
6
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Chile
4
Cameroon
4
Mozambique
4
Senegal
3
Haiti
3
Venezuela
3
Eastern Europe
3
Russia
3
Ukraine
2
Rwanda
2
Spain
2
Tajikistan
1
Benin
1
Estonia
1
Zimbabwe
1
Philippines
1
Guinea
1
Global
1
USA
1
Asia
1
Tanzania
1
South Africa
1
Nicaragua
1
Angola
1
India
1
Authors & Publishers
Publication Years
Category
Countries
139
Clinical Guidelines
30
Women & Child Health
16
Capacity Building
3
Public Health
3
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
Refugee
97
COVID-19
44
TB
32
Mental Health
19
NTDs
15
Rapid Response
13
Ebola & Marburg
6
Caregiver
4
Zika
3
Specific Hazards
2
HIV
2
Disability
2
Planetary Health
2
Conflict
2
Global Health Education
2
Cholera
1
Pharmacy
1
NCDs
1
Polio
1
AMR
1
Regulation of the Minister of Health of the Republic of Indonesia Number 74 Year 2014: Guidelines for Implementation of Hiv Counseling and Test
COVID-19, General Epidemiological Surveillance Guidelines (Version 6)
Guidelines for Diagnosis & Management of Asthma in Indonesia
Apruébase la Guía Práctica Clínica Nacional sobre Prevención, Diagnóstico y Tratamiento de la Diabetes Mellitus Tipo 2 - Resulocíon 695/2009 Ministerio de Salud (M.S.)
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...
Regulation of the Minister of Health of the Republic of Indonesia on Guidelines for Antiretroviral Treatment
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Síndromes paralíticos, parálisis cerebral, down, trastorno del espectro autista, parkinson y discapacidad mental o psíquica
Serie Documentos Técnico Normativos 442
Clinical Pathway of 10 Most Common Urologic Disease in Indonesia
Guideline for the handling and the disposal of the remains of people who died of COVID-19
PLoS Negl Trop Dis 16(11): e0010885. https://doi.org/10.1371/journal.pntd.0010885
HAT diagnosis in non-endemic countries is rare and can be challenging, but alertness and
surveillance must be maintained to contribute to WHO’s elimination goals. Early detection is
particularly important as it co...
В сборнике представлены статьи специалистов в сфере охраны психического здоровья по различным академическим дисциплинам, включая общую медицину, психиатрию, пси...
